For instance, the lower levels of transforming growth factor‐alpha might suggest a diminished neuroprotective response in ALS, while the decreased activity of the CD40L receptor and Interleukin‐12 subunit beta could indicate alterations in immune cell signalling and cytokine networks in MS and PD. The gene discussed is CD40; the disease is myeloid sarcoma.